CTT Pharmaceutical Holdings, Inc. (CTTH): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Not updated since 2014-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

Older than the company's other figures. The latest EBITDA is for the year ended 2011-12-31, while the company's latest annual report covers the year ended 2014-12-31. Its later filings do not report Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.

-$757.9K
Year ended 2011-12-31
2010-12-31: -$2.00M2011-12-31: -$757.9K-$757.9K
2010-12-31 EBITDA (USD) 2011-12-31
Period endedEBITDAChange YoYSource filing
2011-12-31-$757.9Kn/m2013-03-08, From 2011-01-01
2010-12-31-$2.00Mn/a2012-03-20, From 2010-01-01